Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition
The BMBL 5th Edition (December 2009) is available for US $38 via the Government Printing Office (GPO). Alternatively, you may print the 5th edition in its entirety or by section using the links below.
Document by Sections
- Introduction, Foreword, Editors, Steering Committee, Guest Editors, Contributors [PDF - 255 KB]
- Section I – Introduction [PDF - 255 KB]
- Section II – Biological Risk Assessment [PDF - 317 KB]
- Section III – Principles of Biosafety [PDF - 223 KB]
- Section IV – Laboratory Biosafety Level CriteriaSection IV—Laboratory Biosafety Level Criteria [PDF - 354 KB]
- Section V – Vertebrate Animal Biosafety Level Criteria for Vivarium Research Facilities [PDF - 434 KB]
- Section VI – Principles of Laboratory Biosecurity [PDF - 265 KB]
- Section VII – Occupational Health and Immunoprophylaxis [PDF - 265 KB]
- Section VIII - Agent Summary
Statements [PDF - 1.2 MB]
- Section VIII – A: Bacterial Agents [PDF - 468 KB]
- Section VIII – B: Fungal Agents [PDF - 304 KB]
- Section VIII – C: Parasitic Agents [PDF - 339 KB]
- Section VIII – D: Rickettsial Agents [PDF - 249 KB]
- Section VIII – E: Viral Agents [PDF - 413 KB]
- Section VIII – F: Arboviruses and Related Zoonotic Viruses [PDF - 665 KB]
- Section VIII – G: Toxin Agents [PDF - 339 KB]
- Section VIII – H: Prion Diseases [PDF - 260 KB]
- Appendix A – Primary Containment for Biohazards: Selection, Installation and Use of Biological Safety Cabinets [PDF - 1.5 MB]
- Appendix B – Decontamination and Disinfection [PDF - 299 KB]
- Appendix C – Transportation of Infectious Substances [PDF - 846 KB]
- Appendix D – Agriculture Pathogen Biosafety [PDF - 425 KB]
- Appendix E – Arthropod Containment Guidelines (ACG) [PDF - 207 KB]
- Appendix F – Select Agents and Toxins [PDF - 229 KB]
- Appendix G – Integrated Pest Management (IPM) [PDF - 297 KB]
- Appendix H – Working with Human, NHP and Other Mammalian Cells and Tissues [PDF - 236 KB]
- Appendix I – Guidelines for Work with Toxins of Biological Origin [PDF - 296 KB]
- Appendix J – NIH Oversight of Research Involving Recombinant Biosafety Issues [PDF - 233 KB]
- Appendix K – Resources [PDF - 271 KB]
- Appendix L – Acronyms [PDF - 183 KB]
- Index [PDF - 402 KB]
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - Contact CDC–INFO